Relation between Intracavernosal Dose of Prostaglandin Pge 1 and Mean Duration of Erection in Men with Different Underlying Causes of Erectile Dysfunction

Bratu�, Dejan; Hlebic, Gregor; Hajdinjak, Tine
February 2007
Croatian Medical Journal;2007, Vol. 48 Issue 1, p76
Academic Journal
No abstract available.


Related Articles

  • impotence treatment (Major drug group).  // Royal Society of Medicine: Medicines;2002, p300 

    This article provides information on impotence treatment. These drugs are given to men to treat erectile dysfunction. They are drugs that act on intracavernosal vessels in the penis to cause engorgement with blood, and consequently erection. The agents used formerly were given by direct...

  • Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunction. El-Sakka, A. I. // International Journal of Impotence Research;Mar/Apr2006, Vol. 18 Issue 2, p180 

    We have investigated the reliability of intracavernosal prostaglandin E1 (PGE1) office vs self-injection therapy in patients with erectile dysfunction (ED). A total of 298 male patients with ED were enrolled in this study. In all patients, intracavernosal titration of the PGE1 dose was...

  • Alprostadil effective in erectile dysfunction. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;01/25/98, Vol. 11 Issue 1, p19 

    Announces US Food & Drug Administration's approval of intracavernosal injection of the synthetic prostaglandin E1, alprostadil, for the treatment of erectile dysfunction. Use of the drug delivery system, MUSE (medicated urethral system for erection).

  • Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E1 intracavernosal injection therapy to oral sildenafil citrate. Montorsi, F.; Althof, S.E.; Sweeney, M.; Menchini-Fabris, F.; Sasso, F.; Giuliano, F. // International Journal of Impotence Research;Dec2003, Vol. 15 Issue 6, p444 

    Treatment satisfaction, subanalysed by demographic variables, was evaluated in patients switching from successful intracavernosal prostaglandin E1 (PGE1) therapy to oral sildenafil citrate. The validated Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire was administered at...

  • Caverject.  // Royal Society of Medicine: Medicines;2002, p143 

    This article presents information on the Caverject. This drug is a prostaglandin, alprostadil. It is a prescription-only impotence treatment for men to manage penile erectile dysfunction. It available in a form for injection and is administered by intracavernosal injection into the penis.

  • Rationale for combination therapy of intraurethral prostaglandin E1 and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Nehra, A.; Blute, M.L.; Barrett, D.M.; Moreland, R.B. // International Journal of Impotence Research;2002 Supplement 1, Vol. 14 Issue 1, p38 

    Corpus cavernosum smooth muscle relaxation and hence penile erection are regulated in part by increases in smooth muscle synthesis of the second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). The object of this study was to determine 30-month...

  • erection problems? Duncan, Debbie // Good Medicine (Australian Consolidated Press);Sep2004, p16 

    Focuses on issues related to erectile dysfunction. Attitude of Australian men toward erection problems; Risk factors associated with erection problems; Information resources on erectile dysfunction.

  • Anatomical evaluation of penile venous system by CT cavernosography in patients with erectile dysfunction and venous leakage. Ghafoori, Mahyar; Famili, Peyman // Tehran University Medical Journal;Nov2012, Vol. 70 Issue 8, p494 

    Background: Erectile dysfunction is an important problem in men and an organic cause is found in about 50% of cases. When a vasculogenic etiology is suspected, imaging assessments are of great help. Cavernosography is traditionally recognized as an imaging modality for evaluation of venous...

  • Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports. Markou, S; Perimenis, P; Gyftopoulos, K; Athanasopoulos, A; Barbalias, G // International Journal of Impotence Research;Dec2004, Vol. 16 Issue 6, p470 

    Trials of the efficacy and safety of vardenafil in the treatment of male erectile dysfunction (ED) were meta-analysed. All available databases were searched (January 1, 2001-November 30, 2003). Trials were eligible if they included men with ED, compared vardenafil with placebo, were randomized,...

  • Prophylactic Phenylephrine for Iatrogenic Priapism: A Pilot Study With Peyronie's Patients. Pengbo Jiang; Christakos, Athena; Fam, Mina; Sadeghi-Nejad, Hossein // Korean Journal of Urology;Oct2014, Vol. 55 Issue 10, p665 

    Purpose: Although penile duplex Doppler ultrasonography (PDDU) is a common and integral procedure in a Peyronie's disease workup, the intracavernosal injection of vasoactive agents can carry a serious risk of priapism. Risk factors include young age, good baseline erectile function, and no...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics